MFIM
RDHL

Mesirow Financial Investment Management’s Redhill Biopharma RDHL Stock Holding History

Mesirow Financial Investment Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed -$13K – 117
2021
Q1 		$13K Buy
2
+1
+100% +$8.39K 0.04% 119
2020
Q4 		$8.14K Buy
+1
New +$8.99K 0.03% 100

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

Mesirow Financial Investment Management's RDHL Position: Q2 2021 in Review

Mesirow Financial Investment Management sold out of Redhill Biopharma (RDHL) in Q2 2021, closing a stake of 2 shares — an estimated $13K sold.

Mesirow Financial Investment Management first reported a position in RDHL in Q4 2020 and held it in 2 quarters. The position peaked at $13K in Q1 2021. 48 funds tracked by Wall St. Rank hold RDHL as of Q2 2021.

  • Mesirow Financial Investment Management reported no remaining Redhill Biopharma position as of Q2 2021 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 2 Redhill Biopharma shares in Q2 2021, an estimated $13K.
  • Mesirow Financial Investment Management first reported a position in Redhill Biopharma in Q4 2020 and held it in 2 quarters.
  • Mesirow Financial Investment Management's Redhill Biopharma position peaked at $13K in Q1 2021.
  • 48 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2021.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2021, filed 23 Jul 2021.